Replies to post #336628 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Thanks Raf.

[mrmainstreet]

Thanks for posting this Raf.

Man it sure feels like we've hit a wall for weeks now. What's concerning is the overall market is not growing. JT said we could grow faster than gV but there is no growth at all.

I really hope KM has a plan to jumpstart sales/marketing because this is pathetic.

[ramfan60]

Thanks Raf

[fsulevine]

Thank you for that info! Unfortunately it looks like the pharmacies were replenished with the next batch from Hikma... but it also shows they don’t have a built-up, steady supply yet either.

[MNBioMike]

Another 40,000 hours in the books and no growth. WTF!!!

[Invest83838]

Generic Vascepa Roars Back

I was hoping the every other week trend of

huge gains for Generic Vascepa were over

Looks like it might be every 3rd week at the moment

Welp, another up day for the market, and another down day for AMRN

[Birdbrain Ideas]

Thanks. You're the greatest for posting these each week. I find these increases, however slight, encouraging. You'd have to think momentum will build as the year moves on and more doctors begin seeing patients again as COVID numbers decline.

The percentage boost for generics seems consistent with what's been occurring. It shoots up 25 percent one week and drops 20 percent another, leaving generics seemingly consistently growing at a small pace. JT may have been right when he said he thinks Amarin can outrun generics with script growth.

[ralphey]

AMRN should be lining up suits against insurers and PBM's instead they are tweeting about who knows what . The words of Ross Perot come to mind - couldnt run the third shift of a tastee freeze ......

[concapk]

rafunrafun,

generic scripts (4/9/21) 7739 to (4/16/21) 9077 +diff of 1338 or %17.3

[Number sleven]

Raf, Thanks for the numbers. Do you think today's Pacer update will tell us anything useful?
Sleven,

[rafunrafun]

Sripts for week ending April 23, 2021.

Overall drug TRx are +1.0% w/w.

Vascepa
TRx 83,843; -0.0% (-12) w/w; +1.3% y/y
NRx 38,478; -0.8% w/w; +7.4% y/y
Ref 45,365; +0.6% w/w; -3.4% y/y

Generic Vascepa
TRx 10,727; +18.2% (+1,650) w/w; As % of total V: 11.3%
NRx 5,885; +15.6% w/w; As % of total V: 13.3%
Ref 4,842; +21.4% w/w; As % of total V: 9.6%

Lovaza (Generic & Brand)
TRx 61,302; +0.8% (+472) w/w; +2.7% y/y
NRx 30,368; +0.2% w/w; +9.5% y/y
Ref 30,935; +1.3% w/w; -3.2% y/y